Moreover, TUBA4A’s frequency of detection and protein levels were higher in the early stage LC samples (median levels, 10.9 nM; N = 13) than the control samples (median levels, 2.8 nM; N = 2). This evidence concerns the gene TUBA4A and laryngotracheoesophageal cleft.